Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Actuarial projects have become more intricate, involving external resources and requests beyond the actuarial team's purview. Whether a task appears minor or exceptionally complex, adept project and change management play a pivotal role in successful execution. In this session, we explore practical strategies for tailoring implementation management approaches.

Description: Learn from panelists from different companies as they come together to discuss their experiences.

Description: The Smaller Insurance Company/Chief Actuary Forum presents a unique format for focusing on issues faced by actuaries in leadership positions or actuaries supporting the Chief Actuary. By discussing critical issues with your peers, you will leave with ideas to incorporate in your business environment. The Forum will feature presentations to introduce several of the discussion topics, followed by an opportunity to break into smaller discussion groups and rotate among topics.

Description: The topics of ESG (Environmental, Social & Corporate Governance) and sustainability are an increasing area of focus for insurance companies, and thus actuaries. This webcast provides a primer on these topics along with considerations for US valuation actuaries and their evolution in European insurance markets.

Description: This debate-style presentation focuses on metrics used to measure and manage insurance companies. Changes in accounting bases (LDTI, IFRS17, etc.) challenge historic metrics to be adjusted or replaced to accommodate new regimes. The long-duration nature of revenue recognition and profit emergence is unique to the insurance industry, and there is no debating the importance of accounting regimes to facilitate earnings recognition and comparability. However, insurers face challenges from the inherent mismatch between capital measures and accounting profits. This mismatch creates competing interest when it comes to both management decisions and executive compensation. To provide guidance, experts offer their unique perspectives and opinions to a debate of emerging best practices in accounting KPIs, cash-based metrics, and executive incentives. The discussion will be guided by probing questions, such as: - What challenges are faced by external users of financial statements? - Accounting changes did not impact business economics, so why discuss metrics? - What are examples of historic and emerging accounting and cash-based metrics? - How can insurers implement best practices in financial reporting? At the conclusion of the session, attendees will have an improved appreciation for actuarial valuation, specifically, the critical role that our interpretation of results plays in the broader financial system.

Description: Over the last few years, a significant amount of US annuity and pension business has been reinsured with offshore companies, both affiliated and non-affiliated. Hear experts discuss different reserve and capital regimes between the US and offshore jurisdictions, as well as US regulator concerns and responses. The attendees will learn the reasons companies use offshore reinsurance, and improve their understanding of the discussion of proposals to increase US regulator and consumer comfort with companies outside of US jurisdiction.

Description: The Smaller Insurance Company Section Buzz Groups at the Valuation Actuary Meetings and the SOA Annual Meetings have always generated great discussions, ideas, and opportunities to hear about topics that affect the actuarial work of small companies. Join us for the Smaller Insurance Company Section Buzz Group to discuss the issues affecting Smaller (and larger) Insurance Company actuaries during these emerging changes. Bring your thoughts, opinions, ideas, and participation to discuss our special concerns.

Description: After the arduous journeys IFRS 17 filers underwent to implement the standard, it would only make sense for insurers to seek the best return on their investment post effective date of 1/1/2023. Many insurers are now embarking a new phase of the journey that involves wrapping up any unfinished business as they might have taken a minimum compliance route to finish implementation and thinking about the knock-on effects the new standard has on the way they carry out business and perform financial reporting.

Description: Historically for coinsurance deals some appointed actuaries have only concerned themselves with the reinsurer counterparty risk and in certain cases have ignored 100% coinsurance business in their asset adequacy analyses (AAA). Recently there have been regulatory discussions about concerns relating to asset intensive reinsurance and how these deals may be exposing policyholders to additional risk. Presenters will discuss the recent draft APF 2024-3 and issue brief 'Asset-Intensive Reinsurance Ceded Offshore From U.S. Life Insurers (With Focus on Bermuda)', potential impact to AAA, and modeling considerations.